Analyst Ranking
Top 32%
#1592 out of 5014 analysts
Average Return
+1.56%
Win Rate
49%18 out of 37
Risk vs Reward
Poor
Good

Douglas Miehm's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Oncolytics Biotech IncONCY
+99.38%$0.64$1.28
2025-03-10 -
2025-09-12
Buy
Mannkind CorpMNKD
+62.39%$3.43$5.57
2025-08-07 -
2025-09-12
Buy
Aurinia Pharmaceuticals IncAUPH
+59.81%$5.15$8.23
2022-11-04 -
2023-11-03
Buy
Ligand Pharmaceuticals IncLGND
+52.59%$93.32$142.40
2024-08-07 -
2025-08-06
Buy
Ligand Pharmaceuticals IncLGND
+47.60%$99.60$147.01
2024-08-12 -
2025-08-11
Buy

Douglas Miehm Analyst Color

Get additional color on Douglas Miehm's coverage of popular stocks

Douglas Miehm's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Mannkind CorpMNKD
3Buy$8.00+43.63%Maintains
20 days ago
Ligand Pharmaceuticals IncLGND
6Buy$185.00+11.61%Maintains
a month ago
Aurinia Pharmaceuticals IncAUPH
9Buy$9.00-29.36%Maintains
a month ago
Bausch Health Companies IncBHC
19Hold$10.00+37.74%Maintains
4 months ago
Bausch & Lomb CorpBLCO
13Buy$17.00+11.92%Maintains
5 months ago
Oncolytics Biotech IncONCY
1Buy$5.00+290.63%Maintains
6 months ago
Crh Medical CorpCRHM
1HoldN/AN/ADowngrades
5 years ago
Novadaq Technologies IncNVDQ1
1HoldN/AN/ADowngrades
8 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.